Baker D, Anandhakrishnan A, Tuite-Dalton KA et al.(2016).
How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis. Mult Scler Relat Disord
vol. 10,
127-133.

de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S et al.(2006).
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. EUR NEUROPSYCHOPHARM
vol. 16,
(1)
7-18.

East E, Baker D, Pryce G et al.(2005).
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. Am J Pathol
vol. 167,
(2)
545-554.

Black JA, Dib-Hajj S, Baker D et al.(2000).
Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America
vol. 97,
(21)
11598-11602.